A total of 522 possible targets of CDM and ASA were predicted by Swiss Target Prediction and PharmMapper (Supplementary Table 1), and 607 overlapping targets of MDS, AML and AML-MDS were obtained from the GeneCards database (Supplementary Table 2). This evidence concerns the gene ARSA and myelodysplastic syndrome.